Yuri Sanchez Gonzalez

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Ulcerative Colitis

Top Venues

Advances in therapy

Rheumatology and therapy

Journal of medical economics

Canadian liver journal

This page only lists publications with an associated author ORCID identifier.

Publications

Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa, Yuri Sanchez Gonzalez, Naoki Numajiri, Xiaohe Tang, Russell Miller
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib. Journal of medical economics 27 (1) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa, Yuri Sanchez Gonzalez, Naoki Numajiri, Xiaohe Tang, Russell Miller
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib. Journal of medical economics 27 (1) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy (2024)
Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa, Yuri Sanchez Gonzalez, Naoki Numajiri, Xiaohe Tang, Russell Miller
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib. Journal of medical economics 27 (1) (2024)
Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa, Yuri Sanchez Gonzalez, Naoki Numajiri, Xiaohe Tang, Russell Miller
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib. Journal of medical economics (2024)
Peter C Taylor, Yuri Sanchez Gonzalez, Ryan Clark, Freddy Faccin, Oliver Howell
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries. Rheumatology and therapy 10 (2) (2023)
Peter C Taylor, Yuri Sanchez Gonzalez, Ryan Clark, Freddy Faccin, Oliver Howell
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries. Rheumatology and therapy (2023)
Peter C Taylor, Yuri Sanchez Gonzalez, Ryan Clark, Freddy Faccin, Oliver Howell
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries. Rheumatology and therapy 10 (2) (2023)
Remo Panaccione, Eric B Collins, Gil Y Melmed, Severine Vermeire, Silvio Danese, Peter D R Higgins, Christina S Kwon, Wen Zhou, Dapo Ilo, Dolly Sharma, Yuri Sanchez Gonzalez, Si-Tien Wang
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis. Crohn's & colitis 360 5 (2) (2023)
Peter C Taylor, Yuri Sanchez Gonzalez, Ryan Clark, Freddy Faccin, Oliver Howell
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries. Rheumatology and therapy (2023)
Remo Panaccione, Eric B Collins, Gil Y Melmed, Severine Vermeire, Silvio Danese, Peter D R Higgins, Christina S Kwon, Wen Zhou, Dapo Ilo, Dolly Sharma, Yuri Sanchez Gonzalez, Si-Tien Wang
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis. Crohn's & colitis 360 5 (2) (2023)
Jordan J Feld, Marina B Klein, Yasmine Rahal, Samuel S Lee, Shawn Mohammed, Alexandra King, Daniel Smyth, Yuri Sanchez Gonzalez, Arlene Nugent, Naveed Zafar Janjua
Timing of elimination of hepatitis C virus in Canada's provinces. Canadian liver journal 5 (4) (2022)
Jordan J Feld, Marina B Klein, Yasmine Rahal, Samuel S Lee, Shawn Mohammed, Alexandra King, Daniel Smyth, Yuri Sanchez Gonzalez, Arlene Nugent, Naveed Zafar Janjua
Timing of elimination of hepatitis C virus in Canada's provinces. Canadian liver journal 5 (4) (2022)
Jordan J Feld, Marina B Klein, Yasmine Rahal, Samuel S Lee, Shawn Mohammed, Alexandra King, Daniel Smyth, Yuri Sanchez Gonzalez, Arlene Nugent, Naveed Zafar Janjua
Timing of elimination of hepatitis C virus in Canada's provinces. Canadian liver journal 5 (4) (2022)
Ivane Gamkrelidze, Jean Michel Pawlotsky, Jeffrey Victor Lazarus, Jordan J Feld, Stefan Zeuzem, Yanjun Bao, Ana Gabriela Pires Dos Santos, Yuri Sanchez Gonzalez, Homie Razavi
Progress towards hepatitis C virus elimination in high-income countries: An updated analysis. Liver international : official journal of the International Association for the Study of the Liver 41 (3) (2021)